Sequential dose-intensive paclitaxel plus ifosfamide and carboplatin plus etoposide with autologous stem cell transplantation for germ cell tumor (GCT) patients (pts).

被引:0
|
作者
Kondagunta, GV [1 ]
Bacik, J [1 ]
Bajorin, DF [1 ]
Reich, L [1 ]
Sheinfeld, J [1 ]
Bains, M [1 ]
Bosl, GJ [1 ]
Motzer, RJ [1 ]
机构
[1] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:378S / 378S
页数:1
相关论文
共 50 条
  • [1] Sequential dose-intensive paclitaxel, ifosfamide, carboplatin, and etoposide salvage therapy for germ cell tumor patients
    Motzer, RJ
    Mazumdar, M
    Sheinfeld, J
    Bajorin, DF
    Macapinlac, HA
    Bains, M
    Reich, L
    Flombaum, C
    Mariani, T
    Tong, WP
    Bosl, GJ
    JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (06) : 1173 - 1180
  • [2] Paclitaxel plus ifosfamide followed by high-dose carboplatin plus etoposide in previously treated germ cell tumors
    Kondagunta, G. Varuni
    Bacik, Jennifer
    Sheinfeld, Joel
    Bajorin, Dean
    Bains, Manjit
    Reich, Lillian
    Deluca, John
    Budnick, Amy
    Ishill, Nicole
    Mazumdar, Madhu
    Bosl, George J.
    Motzer, Robert J.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (01) : 85 - 90
  • [3] Paclitaxel (T) plus ifosfamide (I) followed by high-dose carboplatin (C) and etoposide (E) with autologous stem cell support for patients (pts) with previously treated germ cell tumors (GCT): TI-CE results and prognostic factor analysis in 107 pts
    Feldman, D. R.
    Sheinfeld, J.
    Bajorin, D. F.
    Fischer, P.
    Turkula, S.
    Ishill, N.
    Patil, S.
    Bains, M.
    Bosl, G. J.
    Motzer, R. J.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [4] Phase I/II study of paclitaxel plus ifosfamide (TI) followed by high-dose paclitaxel, ifosfamide, and carboplatin (TIC) with autologous stem cell transplant (ASCT) for salvage treatment of germ cell tumors (GCT)
    Jia, Xiaoyu
    Feldman, Darren Richard
    Glezerman, Ilya
    Van Alstine, Lindsay Joy
    Bajorin, Dean F.
    Fischer, Patricia
    Hughes, Amanda
    Sheinfeld, Joel
    Bains, Manjit S.
    Reich, Lilian
    Bosl, George J.
    Motzer, Robert John
    Patil, Sujata
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [5] Salvage treatment with paclitaxel, ifosfamide, and cisplatin plus high-dose carboplatin, etoposide, and thiotepa followed by autologous stem-cell rescue in patients with relapsed or refractory germ cell cancer
    Rick, O
    Bokemeyer, C
    Beyer, J
    Hartmann, JT
    Schwella, N
    Kingreen, D
    Neureither, S
    Metzner, B
    Casper, J
    Wandt, H
    Hartmann, F
    Schmoll, HJ
    Derigs, G
    Gerl, A
    Berdel, WE
    Kanz, L
    Siegert, W
    JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (01) : 81 - 88
  • [6] Phase I/II Study of Paclitaxel Plus Ifosfamide Followed By High-Dose Paclitaxel, Ifosfamide, and Carboplatin with Autologous Stem Cell Reinfusion for Salvage Treatment of Germ Cell Tumors
    Feldman, Darren R.
    Glezerman, Ilya
    Patil, Sujata
    Van Alstine, Lindsay
    Bajorin, Dean F.
    Fischer, Patricia
    Hughes, Amanda
    Sheinfeld, Joel
    Bains, Manjit
    Reich, Lilian
    Bosl, George J.
    Giralt, Sergio A.
    Motzer, Robert J.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2014, 20 (02) : S90 - S90
  • [7] Salvage chemotherapy with high dose carboplatin plus etoposide (HDCE) and peripheral blood stem cell transplant (PBSCT) in patients with germ cell tumors (GCT).
    Einhorn, L. H.
    Williams, S.
    Abonour, R.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 228S - 228S
  • [8] Sequential high dose chemotherapy with paclitaxel and etoposide, carboplatin, melphalan and autologous stem cell support in patients with germ cell tumors; a phase II study
    Koumakis, G.
    Tryfonopoulos, D.
    Vassilomanolakis, M.
    Barbounis, V.
    Res, E.
    Demiri, S.
    Tsoukalas, N.
    Droufakou, S.
    Filis, I.
    Efremidis, A.
    EJC SUPPLEMENTS, 2007, 5 (04): : 305 - 305
  • [10] HIGH-DOSE CARBOPLATIN, ETOPOSIDE AND IFOSFAMIDE FOLLOWED BY AUTOLOGOUS STEM-CELL TRANSPLANTATION IN POOR RISK GERM-CELL TUMORS
    SIEGERT, W
    BEYER, J
    STROHSCHEER, I
    WEISBACH, V
    HEUFT, HG
    OETTLE, H
    ZINGSEM, J
    ECKSTEIN, R
    SCHMOLL, HJ
    HUHN, D
    BONE MARROW TRANSPLANTATION, 1992, 10 : 26 - 26